U.S Disposable Syringes Market Size, Share & Trends Analysis Report By Product (Conventional Syringes, Safety Syringes), By Application (Immunization Injections, Therapeutic Injections), By End-use, By States, And Segment Forecasts, 2023 - 2030

The U.S Disposable Syringes market size was estimated at USD 3.90 billion in 2022 and is expected to surpass around USD 6.62 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 5.44% during the forecast period 2023 to 2032.

Key Takeaways:

  • The safety syringes led the market and accounted for more than 63.55% share of the U.S revenue in 2022. 
  • The therapeutic injections led the market and accounted for more than 85.79% share of the U.S revenue in 2022.
  • The immunization injections segment is anticipated to witness the fastest growth over the forecast period. 
  • The hospitals led the market and accounted for more than 34.95% share of the U.S revenue in 2022. 
  • The other segment is anticipated to witness the fastest growth over the forecast period. 
  • Texas dominated the market and accounted for over 8.32% share of U.S revenue in 2022.

U.S Disposable Syringes Market Report Scope

Report Coverage Details
Market Size in 2023 USD 4.11 Billion
Market Size by 2032 USD 6.62 Billion
Growth Rate From 2023 to 2032 CAGR of 5.44%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product, Application, End-use
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key Companies Profiled Cardinal Health; B. Braun Melsungen; Terumo Corporation; ICU Medical, Inc. (Smiths Medical) Nipro Corporation, BD; Sol-Millennium Medical; CODAN Medizinische Geräte GmbH & Co KG; Cole-Parmer Instrument Company, LLC; Henke-Sass, Wolf, UltiMed, Inc.

 

The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S disposable syringes.

The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S disposable syringes market.

Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

Product Insights

The safety syringes led the market and accounted for more than 63.55% share of the U.S revenue in 2022. The safety syringes are majorly used for administering medications by utilizing specialized and standard techniques. The unsafe injection practices lead to almost 33,800 HIV infections, 315,000 hepatitis C transmissions, and 1.7 million hepatitis B infections every year globally. Unsafe practices such as multiple use of a syringe & needle without taking precautionary measures as guided by the healthcare professionals lead to needlestick injuries. In addition, conventional disposable syringes provide protection to the recipient, but do not assure the safety of patients. Such factors are anticipated to boost the segment growth.

The WHO has issued guidelines for the use of safety syringes to prevent needlestick injuries. The aim of these guidelines is to prevent the reuse of conventional syringes. The International Organization for Standardization (ISO) has also issued a set of requirements for manufacturers of safety syringes to ensure safety and high performance level of the products.

The conventional syringes are the second leading segment in 2022. Conventional syringes are mostly made of plastic with visible graduation and are intended for single use. Some of the advantages of disposable conventional syringes are that they eliminate the risk of infections from blood-borne pathogens, such as HIV, Ebola virus, and Hepatitis B & C. However, less use of disposable conventional syringes & needles in undeveloped countries due to high additional costs for maintenance may hamper the segment growth. The governments in these countries are undertaking initiatives to increase the use of conventional disposable syringes & needles with an aim to reduce the transmission of diseases in patients; thereby, propelling the segment growth over the forecast period.

Application Insights

The therapeutic injections led the market and accounted for more than 85.79% share of the U.S revenue in 2022. Increasing awareness toward blood donations in the country is one of the major factors for driving the segment. For instance, as per the America’s Blood Centers, approximately 3 percent of the U.S. population donates blood each year. There were approximately 7.3 million donors in 2019. High prevalence of diseases such as AIDS, tuberculosis, malaria, and dengue leads to demand for high volume of injections as they are one of the essential requirements for diagnosis and treatment.

Furthermore, developments in drugs and delivery systems is also expected to propel the segment growth. For instance, in 2022, CytoDyn, Inc. has completed phase 3 clinical trial of their injectable HIV drug. This injectable is expected to replace the daily antiretroviral pill dose with once-a-week injection, thus improving the quality of life of the 33.00 million people living with AIDS. The success of this drug is expected to provide great opportunity for the growth of disposable syringes market over the forecast period.

The immunization injections segment is anticipated to witness the fastest growth over the forecast period. The process of vaccination is majorly a mass activity, thus, increasing the risk of transmission of blood-borne pathogens. In such cases, the multiple use of a syringe & needle needs to be avoided to prevent the risk of needlestick injuries. In addition, the type of injections used depends on the safety, cost, and type of vaccine to be administered. Prefilled auto-disable syringes are majorly preferred, provided all the vaccines are available in a prefilled form. This prevents vaccine contamination, increases the accuracy of dose, and reduces the waste generated due to multiple vials.

End-use Insights

The hospitals led the market and accounted for more than 34.95% share of the U.S revenue in 2022. Hospital institutions are the largest market for disposable syringes as they cater to majority of the population at any given time. In terms of volume of disposable syringes, hospitals are observed to be the largest consumer of related products and services. Furthermore, hospitals are considered significant buyers because they have long-term contracts with providers of disposable syringes, which gives them higher negotiation leverage and makes them a larger market for product after-sales services. Furthermore, the increasing rate of hospitalization due to rise in trauma cases, & other infectious diseases; growing number of well-furnished, well-equipped, & advanced hospitals; aging population; and increasing prevalence of chronic diseases are expected to drive the segment growth

The other segment is anticipated to witness the fastest growth over the forecast period. The others section includes academic & medical research centers, ambulatory surgical centers, and defense forces. Increasing healthcare expenditure can boost the number of research centers and academics, owing to which, this segment is anticipated to witness growth over the forecast period. The need for optimum sterility and accuracy in research procedures has resulted in increased demand for sterile disposable syringes in academic and medical research centers. Sterility is of utmost importance in research centers, owing to increasing awareness about possible contamination and increase in academic & research centers. Furthermore, the FDA and other regulatory bodies has set guidelines to review the safety and sterility practices in research labs, which is expected to boost segment growth.

States Insights

Texas dominated the market and accounted for over 8.32% share of U.S revenue in 2022. This is due to the fact that there are many uninsured adults in these states, a high rate of preventable deaths, lack of investment in public health, a large number of people with mental illness who cannot access care, and rising insurance costs that make healthcare more expensive than in many other regions of the country.

In addition, Texas saw the most increase in population—4 million—of any state over the preceding 10 years. Due to difficulties for residents of the state to access and afford the healthcare services. Texas ranked 42nd overall on assessment of the functioning of the healthcare system. Its residents are less likely to report having a regular source of healthcare, which is a crucial indicator of how effectively the healthcare system is performing. It also has the highest number of uninsured people in the nation.

Texas citizens are most likely to report forgoing needed medical care due to cost, while the state's residents pay a larger proportion of their incomes toward health insurance than residents of nearly every other state. In addition, Texas is one of the 14 states that have not yet expanded Medicaid in accordance with ACA rules, leaving millions of working people without insurance.

California disposable syringes market is anticipated to witness the fastest growth over the forecast. In California, approximately 700 hospitalizations per 100,000 people were possibly preventable through effective chronic care management and access to high-quality primary care, based on a composite measure of hospital admission rates for 8 chronic care conditions. The preventable hospitalization rate varied from high of 1,341 in Butte County. to a low of 129 in Mono County.

U.S Disposable Syringes Market Share Insights

Companies that sell U.S disposable syringes are stepping up their efforts to get their products approved so that manufacturers can start mass production. One of the main areas of concern for manufacturers is the avoidance of unintentional needle stick injuries in healthcare settings.

In addition, the market players are adopting various strategies, such as mergers & acquisitions, partnership, product launches and innovations products to strengthen their foothold in the market. For instance, in January 2022 Smith's Medical collaborates with the U.S government to develop a COVID-19 vaccine. In order to support the Operation Warp Speed immunization programme, the cooperation with BARDA and JPEO-CBRND comprises a USD 20 million investment for enhanced syringe and needle device production, which is expected to enhance market growth in the near future. Some prominent players in the U.S disposable syringes market include:

  • Cardinal Health
  • B. Braun Melsungen
  • Terumo Corporation
  • ICU Medical, Inc. (Smiths Medical)
  • Nipro Corporation
  • BD
  • Sol-Millennium Medical
  • CODAN Medizinische Geräte GmbH & Co KG
  • Cole-Parmer Instrument Company, LLC. 
  • Henke-Sass, Wolf
  • UltiMed, Inc.
  • Others

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S Disposable Syringes market.

By Product 

  • Conventional Syringes
  • Safety Syringes
    • Retractable Safety Syringes
    • Non-retractable Safety Syringes

By Application 

  • Immunization Injections
  • Therapeutic Injections

By End-use 

  • Hospital
  • Diagnostic Laboratories
  • Blood Banks
  • Pharmaceutical industry
  • Veterinary purposes
  • Others

By States 

  • Texas
    • Dallas-Fort Worth-Arlington
    • Houston-The Woodlands-Sugar Land
    • San Antonio-New Braunfels
    • Austin-Round Rock-Georgetown
    • McAllen
    • Rest of Texas
  • California
    • Los Angeles-Long Beach-Anaheim
    • San Diego-Chula Vista-Carlsbad
    • San Francisco-Oakland-Berkeley
    • Riverside-San Bernardino
    • Sacramento-Roseville-Folsom
    • Rest of California
  • Florida
    • Miami-Fort Lauderdale-West Palm Beach
    • Tampa-St. Petersburg-Clearwater
    • Orlando-Kissimmee-Sanford
    • Jacksonville
    • North Port-Sarasota-Bradenton
    • Rest of Florida
  • New York
    • New York-Jersey City-White Plains
    • Nassau County-Suffolk County
    • New Brunswick-Lakewood
    • Newark
    • Bridgeport-Stamford-Norwalk
    • Rest of New York
  • Virginia
    • Northern Virginia
    • Hampton Roads
    • Richmond MSA
    • Roanoke MSA
    • Lynchburg MSA
    • Rest of Virginia

Frequently Asked Questions

The U.S Disposable Syringes market size was estimated at USD 3.90 billion in 2022 and is expected to surpass around USD 6.62 billion by 2032

The global U.S disposable syringes market is expected to grow at a compound annual growth rate of 5.44% from 2023 to 2032

Some key players operating in the U.S disposable syringes market include Cardinal Health, B. Braun Melsungen, Terumo Corporation, ICU Medical, Inc. (Smiths Medical), Nipro Corporation, BD, Sol-Millennium Medical, CODAN Medizinische Geräte GmbH & Co KG, Cole-Parmer Instrument Company, LLC, Henke-Sass, Wolf, UltiMed, Inc., among other players.

The growth of U.S disposable syringes market is attributed due to growing prevalence of chronic disorders, increasing adoption of safety syringes, and growing number of surgeries in U.S.

Chapter 1 Methodology And Scope
                   1.1 Market Segmentation And Scope
                       1.1.1 Product
                       1.1.2 Application
                       1.1.3 End-Use
                       1.1.4 State Scope
                       1.1.5 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database:
                       1.3.2 Nova one advisor Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                       1.6.2. Approach 1: Commodity Flow Approach
                       1.6.3 Volume Price Analysis (Model 2)
                       1.6.3.1 Approach 2: Volume Price Analysis
                   1.7 List Of Secondary Sources
                   1.8 List Of Primary Sources
                   1.9 List Of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 Objective 2
                       1.10.3 Objective 3
                       1.10.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 U.S Disposable Syringes Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Ancillary Market Outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 User Perspective Analysis
                       3.3.1 Consumer Behavior Analysis
                       3.3.2 Market Influencer Analysis
                   3.4 List Of Key End-Users
                   3.5 Market Dynamics
                       3.5.1 Market Driver Analysis
                           3.5.1.1 Increase In The Prevalence Of Chronic Diseases
                           3.5.1.2 Growing Incidence Of Hospital-Acquired Infections
                           3.5.1.3 Rise In Cases Of Needle-Stick Injuries
                           3.5.1.4 Paradigm Shift From Reusable Medical Devices To Disposable
Medical Devices
                       3.5.2 Market Restraints Analysis
                           3.5.2.1 Comparatively High One-Time Cost
                       3.5.3 Market Opportunity Analysis
                           3.5.3.1 Rising Number Of Government Initiatives To Curb Infection
                           3.5.3.2 Improvements In Public And Private Hospital Infrastructure
                   3.6 U.S Disposable Syringes: Market Analysis Tools
                       3.6.1 Industry Analysis - Porter’s
                       3.6.2 Swot Analysis, By Pest
                   3.7 Impact Of Covid-19 On Market & Post Pandemic Insights
Chapter 4 U.S Disposable Syringes Market: Segment Analysis, By Product, 2020 - 2032
                   4.1 Definition And Scope
                   4.2 Product Market Share Analysis, 2023 & 2032
                   4.3 Segment Dashboard
                   4.4 U.S Disposable Syringes Market, By Product, 2020 To 2032
                   4.5 Market Size & Forecasts And Trend Analyses, 2020 To 2032
                       4.5.1 Conventional Syringes
                           4.5.1.1 Conventional Syringes Market, 2020 - 2032
                       4.5.2 Safety Syringes
                           4.5.2.1 Safety Syringes Market, 2020 - 2032
                           4.5.2.2. Retractable Safety Syringes
                                4.5.2.2.1 Retractable Safety Syringes Market, 2020 - 2032
                           4.5.2.3 Non-Retractable Safety Syringes
                                4.5.2.3.1 Non-Retractable Safety Syringes Market, 2020 - 2032
Chapter 5 U.S Disposable Syringes Market: Segment Analysis, By Application, 2020 - 2032
                   5.1 Definition And Scope
                   5.2 Application Market Share Analysis, 2023 & 2032
                   5.3 Segment Dashboard
                   5.4 U.S Disposable Syringes Market, By Application, 2020 To 2032
                   5.5 Market Size & Forecasts And Trend Analyses, 2020 To 2032
                       5.5.1 Immunization Injections
                           5.5.1.1 Immunization Injections Market, 2020 - 2032
                       5.5.2 Therapeutic Injections
                           5.5.2.1 Therapeutic Injections Market, 2020 - 2032
Chapter 6 U.S Disposable Syringes Market: Segment Analysis, By End-Use, 2020 - 2032
                   6.1 Definition And Scope
                   6.2 End-Use Market Share Analysis, 2023 & 2032
                   6.3 Segment Dashboard
                   6.4 U.S Disposable Syringes Market, By End-Use, 2020 To 2032
                   6.5 Market Size & Forecasts And Trend Analyses, 2020 To 2032
                       6.5.1 Immunization Injections
                           6.5.1.1 Immunization Injections Market, 2020 - 2032
                       6.5.2 Therapeutic Injections
                           6.5.2.1 Therapeutic Injections Market, 2020 - 2032
Chapter 7 U.S Disposable Syringes Market: State Market Analysis, By Product, By Application, And By End-Use, 2020 - 2032
                   7.1 Definition & Scope
                   7.2 State Market Share Analysis, 2023 & 2032
                   7.3 State Market Dashboard
                   7.4 State Market Snapshot
                   7.5 Market Size, & Forecasts, Volume And Trend Analysis, 2023 To 2032
                   7.6 Texas
                       7.6.1 Texas Disposable Syringes Market, 2020 - 2032
                       7.6.2 Dallas-Fort Worth-Arlington
                           7.6.2.1 Dallas-Fort Worth-Arlington Disposable Syringes Market, 2020 - 2032
                       7.6.3 Houston-The Woodlands-Sugar Land
                           7.6.3.1 Houston-The Woodlands-Sugar Land Disposable Syringes Market, 2020 - 2032
                       7.6.4 San Antonio-New Braunfels
                           7.6.4.1 San Antonio-New Braunfels Disposable Syringes Market, 2020 - 2032
                       7.6.5 Austin-Round Rock-Georgetown
                           7.6.5.1 Austin-Round Rock-Georgetown Disposable Syringes Market, 2020 - 2032
                       7.6.6 Mcallen
                           7.6.6.1 Mcallen Disposable Syringes Market, 2020 - 2032
                       7.6.7 Rest Of Texas
                           7.6.7.1 Rest Of Texas Disposable Syringes Market, 2020 - 2032
                   7.7 California
                       7.7.1 California U.S Disposable Syringes Market, 2020 - 2032
                       7.7.2 Los Angeles-Long Beach-Anaheim
                           7.7.2.1 Los Angeles-Long Beach-Anaheim Disposable Syringes Market, 2020 - 2032
                       7.7.3 San Diego-Chula Vista-Carlsbad
                           7.7.3.1 San Diego-Chula Vista-Carlsbad Disposable Syringes Market, 2020 - 2032
                       7.7.4 San Francisco-Oakland-Berkeley
                           7.7.4.1 San Francisco-Oakland-Berkeley Disposable Syringes Market, 2020 - 2032
                       7.7.5 Riverside-San Bernardino
                           7.7.5.1 Riverside-San Bernardino Disposable Syringes Market, 2020 - 2032
                       7.7.5 Sacramento-Roseville-Folsom
                           7.7.6.1 Sacramento-Roseville-Folsom Disposable Syringes Market, 2020 - 2032
                       7.7.7 Rest Of California
                           7.7.7.1 Rest Of California Disposable Syringes Market, 2020 - 2032
                   7.8 Florida
                       7.8.1 Florida Disposable Syringes Market, 2020 - 2032
                       7.8.2 Miami-Fort Lauderdale-West Palm Beach
                           7.8.2.1 Miami-Fort Lauderdale-West Palm Beach Disposable Syringes Market, 2020 - 2032
                       7.8.3 Tampa-St. Petersburg-Clearwater
                           7.8.3.1 Tampa-St. Petersburg-Clearwater Disposable Syringes Market, 2020 - 2032
                       7.8.4 Orlando-Kissimmee-Sanford
                           7.8.4.1 Orlando-Kissimmee-Sanford Disposable Syringes Market, 2020 - 2032
                       7.8.5 Jacksonville
                           7.8.5.1 Jacksonville Disposable Syringes Market, 2020 - 2032
                       7.8.6 North Port-Sarasota-Bradenton
                           7.8.6.1 North Port-Sarasota-Bradenton Disposable Syringes Market, 2020 - 2032
                       7.8.7 Rest Of Florida
                           7.8.7.1 Rest Of Florida Disposable Syringes Market, 2020 - 2032
                   7.9 New York
                       7.9.1 New York Disposable Syringes Market, 2020 - 2032
                       7.9.2 New York-Jersey City-White Plains
                           7.9.2.1 New York-Jersey City-White Plains Disposable Syringes Market, 2020 - 2032
                       7.9.3 Nassau County-Suffolk County
                           7.9.3.1 Nassau County-Suffolk County Disposable Syringes Market, 2020 - 2032
                       7.9.4 New Brunswick-Lakewood
                           7.9.4.1 New Brunswick-Lakewood Disposable Syringes Market, 2020 - 2032
                       7.9.5 Newark
                           7.9.5.1 Newark Disposable Syringes Market, 2020 - 2032
                       7.9.6 Bridgeport-Stamford-Norwalk
                           7.9.6.1 Bridgeport-Stamford-Norwalk Disposable Syringes Market, 2020 - 2032
                       7.9.7 Rest Of New York
                           7.9.7.1 Rest Of New York Disposable Syringes Market, 2020 - 2032
                   7.10 Virginia
                       7.10.1 Virginia Disposable Syringes Market, 2020 - 2032
                       7.10.2 Northern Virginia
                           7.10.2.1 Northern Virginia Disposable Syringes Market, 2020 - 2032
                       7.10.3 Hampton Roads
                           7.10.3.1 Hampton Roads Disposable Syringes Market, 2020 - 2032
                       7.10.4 Richmond Msa
                           7.10.4.1 Richmond Msa Disposable Syringes Market, 2020 - 2032
                       7.10.5 Roanoke Msa
                           7.10.5.1 Roanoke Msa Disposable Syringes Market, 2020 - 2032
                       7.10.6 Lynchburg Msa
                           7.10.6.1 Lynchburg Msa Disposable Syringes Market, 2020 - 2032
                       7.10.7 Rest Of Virginia
                           7.10.7.1 Rest Of Virginia Disposable Syringes Market, 2020 - 2032
Chapter 8 U.S Disposable Syringes Market - Competitive Analysis
                   8.1 Recent Developments & Impact Analysis, By Key Market Participants
                   8.2 Company Categorization
                       8.2.1 Innovators
                       8.2.2 Market Leaders
                   8.3 Vendor Landscape
                       8.3.1 Key Company Market Share Analysis, 2021
                       8.3.2 Major Deals And Strategic Alliances
                           8.3.2.1 New Product Launch
                           8.3.2.2 Expansion
                           8.3.2.3 Acquistion
                       8.3.3 Market Entry Strategies
                   8.4 Company Profiles
                       8.4.1 Cardinal Health
                           8.4.1.1 Company Overview
                           8.4.1.2 Financial Performance
                           8.4.1.3 Product Benchmarking
                           8.4.1.4 Strategic Initiatives
                       8.4.2 B. Braun Melsungen
                           8.4.2.1 Company Overview
                           8.4.2.2 Financial Performance
                           8.4.2.3 Product Benchmarking
                           8.4.2.4 Strategic Initiatives
                       8.4.3 Terumo Corporation
                           8.4.3.1 Company Overview
                           8.4.3.2 Financial Performance
                           8.4.3.3 Product Benchmarking
                           8.4.3.4 Strategic Initiatives
                       8.4.4 Icu Medical, Inc. (Smiths Medical)
                           8.4.4.1 Company Overview
                           8.4.4.2 Financial Performance
                           8.4.4.3 Product Benchmarking
                           8.4.4.4 Strategic Initiatives
                       8.4.5 Nipro Corporation
                           8.4.5.1 Company Overview
                           8.4.5.2 Financial Performance
                           8.4.5.3 Product Benchmarking
                           8.4.5.4 Strategic Initiatives
                       8.4.6 Becton, Dickinson And Company (Bd)
                           8.4.6.1 Company Overview
                           8.4.6.2 Financial Performance
                           8.4.6.3 Product Benchmarking
                           8.4.6.4 Strategic Initiatives
                       8.4.7 Sol-Millennium Medical
                           8.4.7.1 Company Overview
                           8.4.7.2 Financial Performance
                           8.4.7.3 Product Benchmarking
                           8.4.7.4 Strategic Initiatives
                       8.4.8 Codan Medizinische Geräte Gmbh & Co Kg
                           8.4.8.1 Company Overview
                           8.4.8.2 Financial Performance
                           8.4.8.3 Product Benchmarking
                           8.4.8.4 Strategic Initiatives
                       8.4.9 Cole-Parmer Instrument Company, Llc.
                           8.4.9.1 Company Overview
                           8.4.9.2 Financial Performance
                           8.4.9.3 Product Benchmarking
                           8.4.9.4 Strategic Initiatives
                       8.4.10 Henke-Sass, Wolf
                           8.4.10.1 Company Overview
                           8.4.10.2 Financial Performance
                           8.4.10.3 Product Benchmarking
                           8.4.10.4 Strategic Initiatives
                       8.4.11 Ultimed, Inc.
                           8.4.11.1 Company Overview
                           8.4.11.2 Financial Performance
                           8.4.11.3 Product Benchmarking

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert